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OBJECTIVES This study was designed to assess the risk of systemic embolization in patients with left-sided
infective endocarditis, once adequate antibiotic treatment had been initiated, on the basis of
prospective clinical follow-up.
BACKGROUND As one of the complications of infective endocarditis, embolization has a great impact on
prognosis. Prediction of an individual patient’s risk of embolization is very difficult.
METHODS We studied 217 episodes of left-sided endocarditis that were experienced among a cohort of
211 prospectively recruited patients. According to the Duke criteria, 91% of the episodes were
definite infective endocarditis. Seventy-two episodes involved infections located on prosthetic
valves. All patients were studied by transthoracic and transesophageal echocardiography.
Clinical, echocardiographic and microbiologic data were entered in a data base. The mean
follow-up interval was 151 days.
RESULTS Twenty-eight episodes (12.9%; group I) of endocarditis had embolic events after the initiation
of antibiotic therapy. The remaining 189 episodes did not embolize (group II). Most emboli
(52%) affected the central nervous system, and 65% of the embolic events occurred during the
first two weeks after initiation of antibiotic therapy. Previous embolism was associated with
new embolism (relative risk [RR] 1.73, 95% confidence interval [CI] 1.02 to 2.93; p  0.05).
There was an increase in the risk of embolization with increasing vegetation size (RR 3.77,
95% CI 0.97 to 12.57; p  0.07). Vegetation size had no impact on the risk of embolization
in streptococcal endocarditis or aortic infection. By contrast, large (10 mm) vegetations had
a higher incidence of embolism when the microorganism was staphylococcus (p  0.04) and
the mitral valve was infected (p  0.03). The increase in vegetation size at follow-up showed
a higher risk for embolization (RR 2.64, 95% CI 0.98 to 7.16; p  0.02).
CONCLUSIONS Embolism before antimicrobial therapy is a risk factor for new emboli. The risk of
embolization seems to increase with increasing vegetation size, and this is particularly
significant in mitral endocarditis and staphylococcal endocarditis. An increase in vegetation
size, despite antimicrobial treatment, may predict later embolism. (J Am Coll Cardiol 2002;
39:1489–95) © 2002 by the American College of Cardiology Foundation
As one of the complications of infective endocarditis,
embolization has a great impact on the patient’s prognosis.
Systemic embolization is said to occur in 22% to 50% of
cases of endocarditis, and most emboli involve the central
nervous system (1). Prediction of an individual patient’s risk
of embolization has proven to be very difficult. Emboli can
occur before diagnosis, during treatment or after therapy is
completed. Notwithstanding, some investigators maintain
that the rate of embolization decreases after adequate
antibiotic therapy (2).
Some studies have attempted to use echocardiography to
identify a high-risk group of patients who might benefit
from early surgery to avoid embolization (2–17). However,
definitive conclusions cannot be drawn, for several reasons:
transesophageal echocardiography (TEE) was not per-
formed in every study (2–8,11); some studies were retro-
spective (2,11,16); and trials have been composed of heter-
ogeneous populations, including patients with right- and
left-sided endocarditis (9–11,17). In addition, many other
clinical and microbiologic aspects of this disease may be
involved in the risk of embolization.
With all these considerations in mind, we undertook an
investigation to assess the risk of systemic embolization in
patients with left-sided infective endocarditis, once ade-
quate antibiotic treatment had been initiated, on the basis of
prospective clinical follow-up. There were two main objec-
tives of this study: 1) to know the incidence of embolic
events after the institution of adequate antimicrobial ther-
apy; and 2) to assess the clinical relevance of the vegetation
size, type of microorganism and valve infected.
METHODS
Patient group. This clinical study examined 217 episodes
of left-sided endocarditis, experienced among a cohort of
211 patients who were prospectively recruited between April
1996 and June 2000. All patients with the diagnosis of
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endocarditis (n  211; 135 men and 76 women; mean age
57 15 years) in the five centers were included in the study.
In 84 episodes (38.7%), the patient was 65 years old.
According to the Duke criteria, 198 episodes (91%) were
definite and 19 (9%) were possible infective endocarditis
(18). Seventy-two episodes (33%), involved infections lo-
cated on the prosthetic valve; 37 involved early (1 year)
and 35 involved late (1 year) prosthetic valve endocarditis.
In 66 episodes (30%), both valves—mitral and aortic—were
affected by the disease.
Patients were clinically followed for 1 to 942 days (mean
follow-up interval of 151 days). Since the beginning of the
study, all historical, clinical, laboratory, echocardiographic
and microbiologic data were entered in a data base specif-
ically designed for this investigation.
Definition of terms. “Embolic events” were diagnosed by
the clinical investigators who took care of these patients.
The diagnosis of embolism was clinical (i.e., on the basis of
clinical signs [e.g., acute onset of organ system dysfunction
according to symptoms and signs found during physical
examination] and data derived from radiologic procedures
[e.g., tomography, echocardiography, arteriography, mag-
netic resonance imaging]). Cutaneous manifestations of
endocarditis were excluded from the analysis because their
pathogenesis is still questionable and they do not contribute
to morbidity or mortality. Embolic events occurring before
treatment were recorded separately from emboli occurring
after the initiation of antibiotic treatment.
“Adequate antibiotic therapy” was defined as high-dose
intravenous antibiotic combinations known to be bacteri-
cidal in vitro against the isolated microorganisms. Empiric
antibiotic regimens were chosen for culture-negative cases.
Echocardiography. The echocardiographic examinations
were done with commercially available instruments
(Toshiba, Advanced Technology Laboratories and
Hewlett-Packard). All patients were subjected to both
modalities of echocardiographic imaging—transthoracic
echocardiography (TTE) and TEE. The TTE examination
was performed before starting adequate antibiotic therapy.
The TEE examination was performed within 72 h of TTE,
but in many cases, both were performed consecutively. Both
echocardiographic modalities were used before any occur-
rence of a new embolic event. The TEEs were performed
with a 5-MHz transducer, following the standard proce-
dure, and the probes used were monoplane (n  11),
biplane (n  90) and multiplane (n  116). In all patients,
TEE was done within 72 h of starting antibiotic therapy.
During follow-up (mean 14  10 days), TEE was repeated
in 122 episodes.
A “valvular vegetation” was defined as a localized mass of
shaggy echoes adherent to a valve leaflet or prosthetic material
with a distinctive erratic motion. The morphologic character-
istics of vegetations—size, mobility and echogenicity—were
analyzed by TEE. M-mode tracing of the masses was per-
formed to better define the motion of these structures. Non-
specific valvular thickening was not interpreted as a vegetation.
Vegetations were measured in various planes, and the maxi-
mum diameter was used for subsequent analysis. In cases of
multiple vegetations or mitro-aortic endocarditis, the largest
vegetation was measured. The mobility of vegetations was
categorized in three grades, as follows: grade I insignificant,
independent motion; grade IImotion between grades I and
III; grade III  a highly mobile vegetation, usually peduncu-
lated, with the motion of the vegetative mass at an angle
superior to 90°. Echogenicity was also graded in three catego-
ries: low  mass with equal or less echogenicity than that of
myocardial echoes; intermediate  echogenicity between low
and high; and high  mass with equal or higher reflectivity
than that of pericardial tissue.
The existence of periannular complications (e.g., abscesses,
pseudoaneurysms, fistulae) was specifically sought. A “perival-
vular abscess” was defined as a circular or more irregularly
delineated region (10 mm) of reduced echo density without
flow in its interior. When flow into these cavities was detected,
the lesion was named “pseudoaneurysm,” and generally it
appeared as a pulsatile echo-free perivalvular pouch. A “fistula”
was defined as a color Doppler tract communicating between
two adjacent cardiac chambers.
Valvular regurgitation and its severity were graded by
color Doppler imaging, using semiquantitative standard
criteria (19,20).
Statistical analysis. The Student t test or analysis of
variance was used to compare continuous variables (ex-
pressed as the mean value  SD), whereas categorical
variables were compared using the chi-square test. Variables
shown to have significant influence by univariate analysis
were included in a multivariate logistic regression analysis.
Adjusted relative risks (RR) and 95% confidence intervals
(CI) were calculated with the use of the estimated regression
coefficients and their standard errors in the logistic regres-
sion analysis. The existence of interactions was evaluated.
Variables with a p value  0.15 in the univariate analysis
were selected for the multivariate analysis. The null hypoth-
esis was rejected in each statistical test when p  0.05. For
data analysis, the statistical program Windows SPSS, ver-
sion 10.0, was used.
RESULTS
Embolic events. There were 34 embolic events accompa-
nying 28 of 217 episodes of endocarditis (12.9%; group I)
after the initiation of antibiotic therapy. Six of these
episodes had two embolisms each. The sites of embolization
Abbreviations and Acronyms
CI  confidence interval
RR  relative risk
TEE  transesophageal echocardiography
TTE  transthoracic echocardiography
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were the central nervous system (n  18, 52%), superior
extremities (n  3, 9%), inferior extremities (n  7, 21%)
and renal and splenic circulation (n  6, 18%). Twenty-two
(65%) of these emboli occurred within the first two weeks
after TEE and antibiotic therapy. The remaining 189
episodes did not embolize (group II). The number of
embolic events during the whole course (before, during and
after treatment) of the episodes of endocarditis was 91 (71
episodes, 32.7%).
Clinical and microbiologic data. There were no statistical
differences between episodes with and those without emboli
in terms of age (54  17 vs. 57  15 years, p  0.32),
gender (57% vs. 66% males, p  0.40), the incidence of
atrioventricular block (7.1% vs. 9.0%, p  1), the duration
of symptoms before diagnosis (15 days: 42.9% vs. 44.1%,
p  1), the need for surgery (46.4% vs. 54.0%, p  0.54) or
mortality (42.9% vs. 30.2%, p  0.19). The most frequent
pre-existing heart diseases were the presence of a prosthetic
valve (n  76, 35%), rheumatic valve disease (n  26, 12%)
and degenerative valve disease (n  21, 9.8%). Sixty-four
episodes (29.5%) had no detectable pre-existing heart con-
dition. There were no differences in the incidence of
embolism on the basis of pre-existing heart disease, presence
of atrial fibrillation, anticoagulation or predisposing sys-
temic conditions, except for the case of intravenous drug use
(RR 3.12, 95% CI 1.31 to 7.43, p  0.04). There were no
statistically significant differences in the incidence of embo-
lism on the basis of the location of infection (posterior vs.
anterior mitral leaflet, and native vs. prosthetic valve) (Fig.
1 and 2). Nonetheless, the risk of embolism was higher in
episodes of mitral endocarditis than in episodes of aortic
endocarditis. In 11 episodes, the site of valve involvement
could not be determined. Previous embolism occurred in 11
patients in group I (39%), and it showed a higher risk of a
new embolism (RR 1.73, 95% CI 1.02 to 2.93, p  0.05).
There were no significant differences in the risk of
embolism according to the infecting microorganism (Table
1). Staphylococcus aureus (38 episodes), Streptococcus viridans
(34 episodes) and coagulase-negative staphylococci (29 ep-
isodes) were the microorganisms most frequently isolated.
Streptococcus and Enterococcus showed the greatest improve-
ment in embolic risk after the institution of antibiotic
therapy. In early prosthetic valve endocarditis, the most
commonly isolated microorganisms were staphylococci (n
21, 58.3%), whereas in late prosthetic endocarditis, they
were staphylococci (n  8, 22.9%), S. viridans (n  6,
17.1%) and enterococci (n  6, 17.1%). Thirty-two epi-
sodes (15%) were culture-negative.
Surgery was performed in 115 episodes (53%) because of
one of the following situations: heart failure (47 episodes),
persistent signs of infection (17 episodes), persistent signs of
infection and heart failure (14 episodes), severe valvular
dysfunction (27 episodes), periannular complications (3
episodes) and embolization (7 episodes; in 6 instances the
Figure 1. Risk of embolism stratified by the location of infection. Ao  native aortic valve; Ao. Biol  biologic aortic prosthesis; Ao. Mech  mechanical
aortic prosthesis; Mi  native mitral valve; Mi. Biol  biologic mitral prosthesis; Mi. Mech  mechanical mitral prosthesis.
Figure 2. Risk of embolism stratified by location of infection, valve type
and mitral leaflet.
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patient had 2 major embolic events). No patient underwent
surgery solely because of the size of the vegetation.
Echocardiography. Echocardiography was able to identify
vegetative masses in 119 episodes by TTE (54.8%) and in
185 episodes by TEE (85.3%, p  0.001). Transesophageal
echocardiography could not detect vegetations in 26 epi-
sodes of endocarditis. When the episodes with echocardio-
graphically documented vegetations were compared with
those without vegetations, a similar frequency of emboliza-
tion was found in both echocardiographic modalities (Table
2). The mean size of the vegetations was 15.2  8.6 mm
(range 2 to 47). The vegetation size as shown by TEE was
found to be a risk factor for embolism. There was an
increase in the risk of embolization with increasing vegeta-
tion size—from 6.5% at10 mm to 20.8% at20 mm (RR
3.77, 95% CI 0.97 to 12.57) (Fig. 3). Among episodes with
streptococcal endocarditis, the vegetation size had no effect
on the risk of embolization, by contrast with those cases
with staphylococcal endocarditis, which was associated with
a higher incidence of embolism when the vegetation was
large (10 mm) (Table 3). The vegetation size in the mitral
position tended to be larger than that in the aortic position
(17.11 9.11 vs. 14.43 9.9 mm, p 0.07), but it was not
statistically significant. The size of vegetations also tended
to be larger in native valves than in prosthetic valves (16.5
9.9 vs. 13.46  8.3 mm, p  0.058), but, again, it did not
reach a statistically significant difference. The effect of
vegetation size on the valve infected was also studied: larger
vegetations were associated with a higher incidence of
embolism when the mitral valve was infected, although this
was not the case when the aortic valve was involved (Table
3). The development of heart failure, the need for surgery,
and death were not shown to be associated with vegetation
size (10 mm. vs. 10 mm: 58.7% vs. 60.5%, p  0.6;
47.8% vs. 57.3%, p  0.3; and 28.3% vs. 32.2%, p  0.7,
respectively). Changes in vegetation size during antibiotic
treatment were assessed by TEE. Modification of vegeta-
tion size at follow-up, especially an increase in size, was
shown to be associated with a higher risk of embolization
(Table 2). Vegetation mobility and echogenicity were not
statistically different between groups I and II (Table 2).
Periannular complications were documented by echocardi-
ography or demonstrated by anatomy (surgery or necropsy)
in 82 episodes. There were 52 abscesses, 37 pseudoaneu-
rysms and 13 fistulae. There was no relationship between
the existence of these perivalvular complications and the
incidence of embolism (Table 2).
After including previous embolisms, localization of the
infection, type of microorganism and vegetation size in a
multivariate analysis, the only independent variable predic-
tive of embolism was vegetation size (Fig. 3).
DISCUSSION
One of the most devastating consequences of endocarditis is
systemic embolization. For the clinician who takes care of
the patient, it is essential to be able to avoid this serious
complication. It has been demonstrated that once antibiotic
therapy is initiated, the rate of embolism decreases dramat-
ically (12). Therefore, with this important fact in mind, this
study focused on embolization after the initiation of ade-
quate antibiotic therapy. This series is unique compared
with other studies, in the following ways: 1) The period of
observation for embolic events was defined; this was not the
case in most series (10,11,16,17). 2) Our study is prospective
and was especially designed to investigate embolism in
endocarditis; many other studies are retrospective (2,11,16).
3) This is a large-scale study, the largest to date, with a
homogeneous population of patients with native and pros-
thetic valves. Patients with right-sided endocarditis were
not included, as they were in many other studies (9–11,17).
Table 1. Risk of Embolism According to the
Infecting Microorganism
Microorganisms
Risk Before and
After Starting
Antibiotic Therapy
Risk After
Antibiotic
Therapy
Staphylococcus aureus 34.2 (38) 13.2 (38)
Coagulase–negative staphylococci 34.5 (29) 17.2 (29)
Streptococcus viridans 29.4 (34) 8.8 (34)
Enterococcus 30.8 (26) 7.7 (26)
Streptococcus bovis 28.6 (7) 0 (7)
Other streptococci 42.1 (19) 10.5 (19)
Gram-negative bacilli 36.4 (11) 18.2 (11)
Fungi 66.7 (6) 50.0 (6)
Others 45.4 (11) 16.7 (12)
Culture negative 21.9 (32) 12.5 (32)
p Value 0.69 0.54
Data are presented as the percentage (n) of patients.
Table 2. Echocardiographic Data: Prognostic Factors of
Embolism by Univariate Analysis
Risk RR (95% CI) p Value
Perivalvular complications 0.84
Yes 13.4 (82) 1.06 (0.52–2.16)
No 12.6 (135) 1
Vegetation size at follow-up 0.02
Increase 26.7 (15) 2.64 (0.98–7.16)
No change 10.1 (119) 1
Decrease 22.6 (31) 2.24 (0.96–5.21)
Vegetations by TTE 0.84
Yes 13.6 (118) 1.11 (0.56–2.25)
No 12.1 (99) 1
Vegetations by TEE 0.58
Yes 13.6 (184) 1.49 (0.48–4.67)
No 9.1 (33) 1
Echogenicity by TEE 0.56
Low 20.0 (35) 1
Intermediate 14.0 (86) 0.70 (0.30–1.62)
High 10.7 (28) 0.54 (0.15–1.88)
Mobility by TEE 0.58
Grade I 7.1 (14) 1
Grade II 12.8 (39) 1.79 (0.23–14.06)
Grade III 16.3 (98) 2.29 (0.33–15.92)
Risk data are presented as the percentage (n) of patients.
CI  confidence interval; RR  relative risk; TEE  transesophageal echocar-
diography; TTE  transthoracic echocardiography.
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4) In most studies, the embolic events that took place before
antibiotic treatment and before echocardiography are in-
cluded in the statistical analysis. This increases the number
of episodes with embolism and small or no vegetations. In
addition, this policy underestimates the effect of antibiotic
therapy on the risk of embolization. In this study, echocar-
diography was performed at the beginning of the risk
period; we were thereby able to evaluate the potential of
vegetation status to predict embolization under adequate
antibiotic treatment. Finally, 5) the use of TEE improves
the vegetation detection rate and, because of better visual-
ization, should also improve the accuracy of measurements;
most previous studies used TTE (2–8,11).
In our study, the incidence of embolization after antibi-
otic therapy was 12.9%, much less than the incidence of
embolism during the whole course of the endocarditis
episode (32.7%). We, like Steckelberg et al. (2), have
demonstrated that the risk of embolic events very clearly
drops after the second week of successful antibiotic treat-
ment (65% of embolisms took place during the first two
weeks of therapy). In this series, six episodes of endocarditis
had two major embolic events each; therefore, only six
patients underwent surgery by reason of this traditional
surgical indication alone. As in other studies (1), we found
that the most frequent site of embolization was the central
nervous system (53%). In our study, intravenous drug users
were at higher risk of embolism. The number of intravenous
drug users in our study group is small, and this may have
contributed to a population bias.
Vegetation morphology. Vegetations are the primary le-
sion in patients with endocarditis. Despite the new echo-
cardiographic imaging technology, the sensitivity of TTE in
this series was inferior to that of TEE. The difference in the
vegetation detection rate between the two echocardio-
graphic modalities was most striking in prosthetic valve
endocarditis. Most episodes of endocarditis in this series
had vegetations detected by TEE (85%). Consequently, the
prognostic implications, if any, would probably be more
dependent on vegetation morphology than on the presence
or absence of vegetations alone.
The relevance of vegetation size as a predictor of embo-
lism has previously been argued in echocardiographic stud-
ies. Our findings are in agreement with several studies and
in disagreement with others. Much of this controversy
stems from the fact that the majority of studies included a
small number of patients, thereby introducing the possibility
of beta error. In the study by Mu¨gge et al. (10), when the
infection involved a native aortic or prosthetic valve (in
either the aortic or mitral position), the size of the vegeta-
tion was not significantly different between episodes involv-
ing embolism and those not involving embolism. However,
among patients with an infected native mitral valve, those
with a large vegetation (10 mm) had a higher incidence of
embolism than those with a small vegetation. In the study
by Mu¨gge et al., some echocardiograms were obtained after
the emboli were known to have occurred, and a temporal
relationship among antimicrobial therapy, emboli and TEE
was not controlled. Tischler and Vaitkus (21) undertook a
meta-analysis to determine whether vegetation size is an
important determinant of clinical outcome. Their results
Figure 3. Risk of embolism stratified by vegetation size. CI  confidence interval; RR  relative risk.
Table 3. Effect of Vegetation Size on Embolism Stratified by
Type of Microorganism and Valve Infected
Risk RR (95% CI) p Value
Streptococcus
10 mm 0.0 (10) Undefined 1.00
10 mm 7.5 (40) 1
Staphylococcus
10 mm 0.0 (16) Undefined 0.04
10 mm 23.7 (38) 1
Aortic position
10 mm 6.9 (29) 0.64 (0.14–2.99) 0.71
10 mm 10.7 (56) 1
Mitral position
10 mm 0.0 (16) Undefined 0.03
10 mm 23.5 (68) 1
Risk data are presented as the percentage (n) of patients.
Abbreviations as in Table 2.
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support the hypothesis that large (10 mm), left-sided
vegetations pose an increased risk of systemic embolization.
However, several studies were not included in their analysis;
selection of the studies was not done within a quality scale;
a measurable period to evaluate the embolic event was not
defined; and finally, it was an observational study, and the
univariate RRs were done without adjustments. Therefore,
their conclusions were global, and they did not consider
other variables. Many other drawbacks could be pointed out
in this meta-analysis (21). The present study showed a
clinically relevant increase in the risk of embolization with
increasing vegetation size (Fig. 3). As in the study by
Mu¨gge et al. (10), the impact of vegetation size on embo-
lism was statistically significant in the mitral position and in
staphylococcal endocarditis.
Normally, a large, pedunculated vegetation is also a very
mobile one, and therefore, mobility was not a further
independent variable to determine the patient’s risk of
embolism. Other investigators have hypothesized that the
echogenicity of a vegetation could have prognostic signifi-
cance (8,16,22). In theory, a low-density vegetation would
correspond to a fresh and friable vegetation, and conse-
quently, it would have a greater capacity to embolize than a
high-density vegetation, which would signify a more
chronic and healed vegetative mass. Our data demonstrate
that there is no relationship between the echogenicity of the
vegetation and the risk of embolization. Other investigators
have found similar results (16). We used a very simple data
analysis to study vegetation echogenicity, which can be
easily used in every echocardiography laboratory. Nonethe-
less, it probably has a lot of technical drawbacks (e.g., gain,
setting, lateral resolution) that could prevent proper tissue
characterization. Furthermore, we know that vegetations are
not static lesions, but are very dynamic, and in most cases,
the vegetative mass is heterogeneous in composition, with a
mixture of both chronic and fresh areas. Thus, this evalua-
tion parameter does not seem to be very useful for wide-
scale analyses of patients with endocarditis.
Vegetation size at follow-up. The present study and other
studies (15) have demonstrated that the vegetation mor-
phology changes during the course of this disease. Some
investigators maintain that a reduction in vegetation size
during antibiotic treatment indicates a rapid healing of the
infectious process and that these patients develop fewer
complications (15). The mechanism by which some antibi-
otics may reduce vegetation size is not well known. Some
antibiotics seem to reduce the platelet count and alter
platelet function—aspects that could modify vegetation size.
The reduction of titers of bacterial toxins by antibiotics
could decrease the vegetation size. Also, microembolization
of the more friable parts of the vegetative mass could
diminish the vegetation size. Previous follow-up reports of
vegetation size, using TTE or TEE, are scarce (15). A few
investigators have shown a reduction in vegetation size
during treatment; nonetheless, despite antimicrobial ther-
apy, many vegetations remain constant in size (83.8% in our
series), and this does not worsen the patient’s prognosis. In
our study group, TEE demonstrated an increase in vegeta-
tion size in 10.5% of the episodes of endocarditis; these
episodes involved a higher incidence of embolization than
those not showing an increase in the vegetative mass (Table
2). Other investigators had a similar experience (15). In
many instances (60%), an increase in vegetation size was
accompanied by persistent signs of infection; therefore, an
increase in vegetation size could reflect poor infection
control. The decrease in vegetation size at follow-up also
appeared to increase the embolic risk (Table 2). Our
hypothesis is that fragmentation and embolization of the
vegetation could explain this finding. Along these lines,
TEE might be able to estimate the efficacy of treatment and
thus be used to guide patient management. In the present
study, periannular complications had no significant influ-
ence on the incidence of embolism.
Microorganisms. Previous clinical reports have suggested
that certain microorganisms, such as Staphylococcus and
fungi, carry an increased risk of embolization (1,2). In our
series, although half of the episodes caused by fungi (n  3)
did embolize, there were no significant differences in the
risk of embolism, stratified by the infecting microorganism,
neither after the initiation of antibiotic therapy nor during
the whole course of endocarditis (Table 1). Steckelberg et al.
(2) found that the rate of embolism was higher among
patients with S. aureus endocarditis than among patients
with streptococcal endocarditis. In our study, among pa-
tients with staphylococcal endocarditis, those with large
vegetations had a higher incidence of embolism. In contrast,
among patients with streptococcal endocarditis, the vegeta-
tion size had no impact on the risk of embolization. In the
study by Steckelberg et al., among patients with S. aureus
endocarditis, the presence of vegetations on the echocardio-
gram had no effect on the rate of emboli. Their study
differed from ours in that it was retrospective, the echocar-
diographic modality was TTE, only cases of native valve
endocarditis were included and incidence rate, rather than
risk, was reported.
Previous embolism. Finally, a piece of important informa-
tion is that in the present study, a previous embolism was a
risk factor for new emboli. Other groups had a similar
experience (2), which probably reflects some unknown
patient factors in the risk of embolization.
Study limitations. All emboli in the present study were
symptomatic. It is difficult to assess the real incidence of
embolic events during the course of the disease because
some of them remain clinically silent. In this series, 52
patients had an operation during the first two weeks of
therapy and, consequently, before a potential embolic event.
This bias seems unavoidable because, in most cases, the
surgical indication was heart failure or persistent signs of
infection.
For several of the sub-analyses, the present study may not
have sufficient patient numbers to have adequate power to
demonstrate differences. Nonetheless, we want to empha-
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size the clinical relevance of these findings, as well as the
confidence intervals.
A larger series with a larger number of episodes caused by
common microorganisms (Streptococcus) and also with a
more notorious representation of infrequent microorgan-
isms, such as fungi, gram-negative bacillus, Coxiella and
others, could shed more light on the protagonism of
microorganisms in the embolic risk of patients with endo-
carditis.
Conclusions. The present study demonstrates that embo-
lism after adequate antimicrobial treatment is frequent, and
most emboli occur within the first two weeks of therapy.
Embolism before antimicrobial therapy is a risk factor for
emboli after antimicrobial therapy has begun. Control of
infection plays a leading role in the prevention of embolism.
An increase in vegetation size, as detected by TEE, despite
antimicrobial treatment, may predict a later embolism. The
type of infecting microorganism was not a risk factor for
embolism. The risk of embolization seems to increase with
increasing vegetation size, and this is particularly significant
in mitral valve endocarditis and staphylococcal endocarditis.
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